Literature DB >> 17689402

Stratified age-period-cohort analysis of stroke mortality in Japan, 1960 to 2000.

Enbo Ma1, Hideto Takahashi, Ayako Mizuno, Masafumi Okada, Kazumasa Yamagishi, Hiroyasu Iso.   

Abstract

BACKGROUND: Although stroke mortality has been decreasing in Japan, in 2000 it was still the third leading cause of death among Japanese of either sex. Elucidation of stroke mortality trends among age, calendar year, and birth cohorts should improve stroke prevention efforts. The objective of this study was to clarify the age, period, and cohort effects on stroke mortality in Japan from 1960 to 2000 by using stratified age-period-cohort models with improved goodness of fit.
METHODS: Death and population from the Vital Statistics of Japan and the National Statistics Bureau, respectively, were tabulated among 12 age groups (30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, and 85-89) and 9 quinquennials (1960, 1965, 1970, 1975, 1980, 1985, 1990, 1995, and 2000), which yielded 20 birth cohorts (midyears of 1873, 1878, 1883, 1888, 1893, 1898, 1903, 1908, 1913, 1918, 1923, 1928, 1933, 1938, 1943, 1948, 1953, 1958, 1963, and 1968). A stratified model (age-periods-cohort model) with 7 age classes (30-44, 45-54, 55-64, 65-69, 70-74, 75-79, and 80-89 years) was applied under the assumption that the number of deaths has an extra-Poisson variation.
RESULTS: The stratified model showed that: (1) middle-aged groups (40-64 years in men and 40-59 years in women) had higher mortality than their linear age trends; (2) young (30-44 years) and middle-aged (45-64 years) groups showed different patterns than those of the elderly (65-89 years) age groups: the two younger groups had higher nonlinear period effects than their linear trends between 1970 and 1990, and the trend of decreasing began later (in 1975 in men and 1980 in women, respectively) than it did for the elderly (1970); and (3) the nonlinear cohort effects indicated 4 patterns in each sex, and the effects increased in post-1948 cohort in men and in post-1958 cohort in women.
CONCLUSION: Young and middle age (30-59 years) boosted the mortality, suggesting that this age range should be targeted for increased stroke prevention efforts.

Entities:  

Mesh:

Year:  2007        PMID: 17689402     DOI: 10.1016/j.jstrokecerebrovasdis.2006.11.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  The dynamics of cardiovascular epidemiology.

Authors:  Dag S Thelle
Journal:  Eur J Epidemiol       Date:  2009-12-05       Impact factor: 8.082

2.  Health Disparities in Ischaemic Heart Disease Mortality in Hungary From 1970 to 2010: An Age-Period-Cohort Analysis.

Authors:  Krisztina Gero; Ehab S Eshak; Enbo Ma; Hideto Takahashi; Hiroyuki Noda; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2015-05-16       Impact factor: 3.211

3.  Age-Period-Cohort Analysis of Stroke Mortality Attributable to High Sodium Intake in China and Japan.

Authors:  Jinhong Cao; Ehab S Eshak; Keyang Liu; Krisztina Gero; Zhiming Liu; Chuanhua Yu
Journal:  Stroke       Date:  2019-06-14       Impact factor: 7.914

4.  An Age-Period-Cohort Analysis of Stroke Mortality Attributable to Low Physical Activity in China and Japan: Data from the GBD Study 1990-2016.

Authors:  Jinhong Cao; Ehab S Eshak; Keyang Liu; Jin Yang; Krisztina Gero; Zhiming Liu; Chuanhua Yu
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

5.  An Age-Period-Cohort Analysis of Biomarkers of Lifestyle-Related Diseases Using the National Health and Nutrition Survey in Japan, 1973-2018.

Authors:  Tasuku Okui
Journal:  Int J Environ Res Public Health       Date:  2020-11-04       Impact factor: 3.390

6.  Future projection of the health and functional status of older people in Japan: A multistate transition microsimulation model with repeated cross-sectional data.

Authors:  Megumi Kasajima; Hideki Hashimoto; Sze-Chuan Suen; Brian Chen; Hawre Jalal; Karen Eggleston; Jay Bhattacharya
Journal:  Health Econ       Date:  2020-07-14       Impact factor: 2.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.